Johnson Pharmacare share news, announcements and annual reports
BSE: 532154Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 29 Oct 2026. Previous close ₹0.40.
29 Oct: open ₹0.40, high ₹0.40, low ₹0.36
- Under BSE's graded surveillance, stage 0, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹20 Cr3,837th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 46.76
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −200.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹14 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −150.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −195.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 49.18
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 18,26,111
Johnson Pharmacare has 460 announcements on record, routine notices left out; none in the 30 days to 29 Oct 2026, the latest on 13 Aug 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Johnson Pharmacare quarterly results
The board met on 13 Aug 2026 to consider quarterly results
Notice filed 10 Aug 2026
Johnson Pharmacare annual reports, presentations and earnings calls
The company's own documents, latest first.Johnson Pharmacare financials, year by year
Annual reports23
- Annual report, year to Mar 202523 Aug 2025
- Annual report, year to Mar 20245 Sep 2024
- Annual report, year to Mar 20236 Sep 2023
- Annual report, year to Mar 20225 Sep 2022
- Annual report, year to Mar 202127 Aug 2021
18 earlier reports
- Annual report, year to Mar 202024 Aug 2020
- Annual report, year to Mar 201929 Aug 2019
- Annual report, year to Mar 201822 Oct 2018
- Annual report, year to Mar 20173 Oct 2017
- Annual report, year to Mar 201617 Nov 2016
- Annual report, year to Mar 20154 Dec 2015
- Annual report, year to Mar 201320 Apr 2015
- Annual report, year to Mar 201420 Apr 2015
- Annual report, year to Mar 20124 Dec 2012
- Annual report, year to Mar 201131 Jan 2012
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
Johnson Pharmacare share news and announcements
Newest first. Page 1 of 10.
Aug 2026
13 Aug · Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On June 30Th, 2026.
11 Aug · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
10 Aug · Board meeting
Meeting on 13 Aug 2026: quarterly results
Jun 2026
12 Jun · Management
1 Jun · Outcome Of Meeting Of Board Of Directors Held On Wednesday, 27Th May, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
May 2026
27 May · Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015.
27 May · Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter And Financial Year Ended On March 31St, 2026.
22 May · Board meeting
Meeting on 27 May 2026: audited results9 May · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Apr 2026
17 Apr · Board meeting
Meeting on 17 Apr 202617 Apr · Management
Feb 2026
14 Feb · Undertaking For Non-Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On 31St December, 2025.
12 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results5 Feb · Board meeting
Meeting on 12 Feb 2026: quarterly resultsNot held on this date
2 Feb · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
Jan 2026
21 Jan · Management
8 Jan · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Nov 2025
24 Nov · Board meeting
Meeting on 24 Nov 202524 Nov · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
24 Nov · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 12 Jun 2026Board or managers changed0.00%−2.2 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−4.9 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 20 Apr 2026Board or managers changeddown 1.61%−1.6 pts vs Nifty 500market median 0.0% · five sessions −6.5% (−5.1 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 18 Feb 2026Board or managers changeddown 1.75%−2.2 pts vs Nifty 500market median 0.0% · five sessions −5.3% (−4.3 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 13 Feb 2026Board or managers changeddown 1.67%−0.2 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−6.8 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 10 Feb 2026Board or managers changeddown 1.64%−1.9 pts vs Nifty 500market median 0.0% · five sessions −4.9% (−4.0 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 1 Feb 2026Board or managers changedup 15.69%+17.7 pts vs Nifty 500market median 0.0% · five sessions +17.6% (+16.2 pts vs Nifty 500) · volume 2.9× usual · The announcement
- 27 Jan 2026Board or managers changeddown 1.92%−2.4 pts vs Nifty 500market median 0.0% · five sessions +13.5% (+13.9 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 22 Jan 2026Board or managers changeddown 1.89%−2.6 pts vs Nifty 500market median 0.0% · five sessions −3.8% (−5.1 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 16 Jan 2026Board or managers changedup 1.79%+1.7 pts vs Nifty 500market median 0.0% · five sessions −7.1% (−5.2 pts vs Nifty 500) · volume 1.3× usual · The announcement